T-cell leukemia 1 expression in nodal Epstein-Barr virus–negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma

2010 ◽  
Vol 41 (9) ◽  
pp. 1238-1244 ◽  
Author(s):  
Gabriela Gualco ◽  
Lawrence M. Weiss ◽  
Glen N. Barber ◽  
Carlos E. Bacchi
2016 ◽  
Vol 28 (6) ◽  
pp. 789 ◽  
Author(s):  
Mi-Hye Lee ◽  
Ik-Jun Moon ◽  
Woo-Jin Lee ◽  
Chong-Hyun Won ◽  
Sung-Eun Chang ◽  
...  

2018 ◽  
Vol 109 (2) ◽  
pp. 221-227 ◽  
Author(s):  
Kazuharu Kamachi ◽  
Takero Shindo ◽  
Masaharu Miyahara ◽  
Kazutaka Kitaura ◽  
Michiaki Akashi ◽  
...  

2008 ◽  
Vol 43 (3) ◽  
pp. 174 ◽  
Author(s):  
Yoon Hee Choi ◽  
Hyo Seog Kim ◽  
Seung Bum Nam ◽  
Hye Jin Kang ◽  
Im Il Na ◽  
...  

2011 ◽  
Vol 52 (10) ◽  
pp. 2027-2030 ◽  
Author(s):  
Sheau-fang yang ◽  
Wen-Yu Chang ◽  
Cheng-Che E. Lan ◽  
Peter G. Isaacson ◽  
Shih-Sung Chuang

2021 ◽  
Author(s):  
Mobin Paul ◽  
Latha Abraham ◽  
MP Sophy ◽  
Dasary Varghese ◽  
Chryselle Olive D'Souza

Epstein Barr virus - positive (EBV+) diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), is a newly recognized rare aggressive B- cell neoplasm with a wide morphologic spectrum. Metachronously developed B- cell and T- cell composite lymphoma (CL) is quite rare. We report a case of an elderly male who presented with enlarged abdominal lymph nodes and diagnosed as EBV+ DLBCL, NOS. He was started on chemotherapy which had to be discontinued after three cycles due to life threatening Pneumocystis carinii pneumonia and poor performance status. While on follow up, within two years, the patient presented with features of relapse. A repeat histopathological examination of the lymph node showed features of Peripheral T cell lymphoma, not otherwise specified (PTCL, NOS) and the clonality was confirmed by T- cell receptor gamma chain rearrangement assay. More studies are needed to understand the association of EBV+ DLBCL, NOS with other lymphomas.


Sign in / Sign up

Export Citation Format

Share Document